What is the recommended infusion duration for a 200 mg vial of Venofer (iron sucrose)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Venofer 200 mg Infusion Duration

For a 200 mg dose of Venofer (iron sucrose), administer as a slow intravenous injection over 2 to 5 minutes undiluted, or as an infusion diluted in a maximum of 100 mL of 0.9% NaCl over 15 minutes. 1

FDA-Approved Administration Options

The FDA label for Venofer provides two specific methods for administering 200 mg 1:

Option 1: Slow IV Injection (Undiluted)

  • Duration: 2 to 5 minutes
  • Preparation: Administer undiluted directly from the vial
  • Volume: 10 mL (200 mg)

Option 2: IV Infusion (Diluted)

  • Duration: Minimum 15 minutes
  • Preparation: Dilute 200 mg in maximum 100 mL of 0.9% NaCl
  • Volume: Total 110 mL

Clinical Context and Evidence

The 200 mg dose is specifically indicated for adult patients with non-dialysis dependent chronic kidney disease (NDD-CKD), administered on 5 different occasions over a 14-day period 1. This dosing schedule provides a total of 1000 mg over two weeks.

Recent guidelines support the convenience of bolus dosing. The 2011 British Society of Gastroenterology guidelines explicitly state that "bolus intravenous dosing of iron sucrose (200 mg iron) over 10 min is licensed and more convenient than a 2 h infusion" 2. This represents a practical evolution from older, more time-consuming infusion protocols.

Real-World Safety Data

A large prospective study of 2,297 injections in 657 patients demonstrated that 200 mg iron sucrose administered as a 2-minute bolus injection is safe and practical 3. In this study:

  • 97.5% of injections proceeded uneventfully
  • Only 7 acute anaphylactoid reactions occurred (0.3%), all resolving within 30 minutes
  • The most common side effect was transient metallic taste (17.9%), which caused no significant distress
  • No cases of phlebitis were recorded

Important Safety Considerations

Monitor patients for hypersensitivity reactions during and for at least 30 minutes after administration 1. Most reactions to intravenous iron occur within 30 minutes of completion. Resuscitation facilities must be immediately available.

Avoid Excessive Doses

While the 200 mg dose is safe, do not exceed 300 mg per infusion based on dose-finding studies. A prospective study found that 500 mg doses caused reactions in 36% of patients (8/22), and 400 mg doses caused reactions in 6% (2/35), characterized by hypotension, nausea, and lower back pain 4. In contrast, both 200 mg and 300 mg doses over 2 hours showed no adverse events in 89 and 189 patients, respectively 4.

Practical Algorithm

For 200 mg Venofer administration:

  1. Verify indication: NDD-CKD with iron deficiency anemia
  2. Choose method based on setting:
    • Outpatient/clinic: 2-5 minute undiluted push (most convenient, FDA-approved)
    • Cautious approach: 15-minute infusion in 100 mL NS
  3. Monitor during infusion and for 30 minutes post-administration
  4. Repeat every 2-3 days for total of 5 doses (1000 mg total)

The 2-5 minute push is preferred for efficiency and patient convenience, supported by both FDA labeling and extensive clinical experience 1, 3. The 15-minute infusion option remains available for clinicians who prefer a more gradual administration or for patients with prior infusion reactions to other agents.

References

Research

Administration of intravenous iron sucrose as a 2-minute push to CKD patients: a prospective evaluation of 2,297 injections.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005

Research

Intravenous iron sucrose: establishing a safe dose.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.